Prognostic factors in RET dependent cancers treateded with RET inhibitors in early phase clinical trials.
Year: 2021
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Max Gordon, Jason Roszik, Maria E. Cabanillas, Mimi I-Nan Hu, Naifa Lamki Busaidy, Steven I. Sherman, Ramona Dadu, Elizabeth Gardner Grubbs, Yasir Y Elamin, Tina Cascone, Lauren Averett Byers, George R. Blumenschein, Frank V. Fossella, Aung Naing, David S. Hong, John Heymach, Funda Meric-Bernstam, Vivek Subbiah
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3172541194